Handelsbanken Fonder AB - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$235
-32.9%
27,9000.0%0.00%
-50.0%
Q2 2023$350
-9.6%
27,900
+18.7%
0.00%0.0%
Q1 2023$387
+10.3%
23,5000.0%0.00%0.0%
Q4 2022$351
-99.9%
23,500
+176.5%
0.00%
+100.0%
Q1 2022$254,000
-40.5%
8,500
-38.8%
0.00%
-50.0%
Q4 2021$427,00013,9000.00%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,030,648$45,277,8813.51%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$416,900,1473.48%
Finepoint Capital LP 714,848$10,6803.45%
Nextech Invest Ltd. 475,485$7,103,7462.83%
BVF INC/IL 3,876,021$57,907,7542.44%
Integral Health Asset Management, LLC 625,000$9,337,5001.96%
EcoR1 Capital, LLC 4,163,824$62,207,5311.89%
Boxer Capital, LLC 2,169,132$32,406,8321.71%
BRANDYWINE MANAGERS, LLC 31,807$475,1971.66%
HighVista Strategies LLC 176,521$2,637,2241.57%
View complete list of RELAY THERAPEUTICS INC shareholders